Other terms
- Telangiectasia
- TIL Therapy
- Ulcerative Colitis
- Unmasking/Unblinding
- Urodynamics
- Uvea
- Vascular Neurology
- Verneuil’s Disease
- Vertical Neck Bands
- Vitiligo
- Vitreoretinal
- Vitreous
T-cell Transfer Therapy
What is T-Cell Transfer Therapy? T-cell transfer therapy, or adoptive T-cell therapy, refers to a class of immunotherapy that involves the extraction of the patient’s T lymphocytes, enhancing their function or proliferation in the lab, and re-introducing through IV after several weeks. During this waiting period, the patient may be given chemo-or radiation therapy.
What are the Types of T-Cell Transfer Therapy?
There are two main types of T-cell transfer therapy:
- Tumor-infiltrating lymphocyte (TIL) therapy
- Chimeric antigen receptor (CAR) T-cell therapy
Source: T-cell Transfer Therapy – Immunotherapy. (2022, April 1). National Cancer Institute. Retrieved September 9, 2022, from https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/t-cell-transfer-therapy
